{
  "id": "mhgap#risk_safety_d7f4cbb3",
  "content": "Strength of recommendation: Strong\nCertainty of evidence: Low\nJustification QT prolongation, sedation, which all appear in\ny Data were extracted from an NMA: Kishi et al., 2022 varying degrees.\n(included 72 RCTs on pharmacological treatment for y According to the systematic review used, the mood\nbipolar mania) (202). stabilizers which were effective – carbamazepine,\ny In the review, the antipsychotics aripiprazole, sodium valproate and lithium – have important\nasenapine, cariprazine, haloperidol, olanzapine, side-effects as well. Rare, but extremely serious\npaliperidone, quetiapine, risperidone side-effects are that carbamazepine is associated\nand ziprasidone and the mood stabilizers with the risk of Stevens-Johnson syndrome and toxic\ncarbamazepine, lithium and sodium valproate epidermal necrolysis (203).\noutperformed placebo significantly for the outcome y An important side-effect of sodium valproate is\nresponse to treatment. The effect sizes were small its teratogenic potential. It significantly increases\nto moderate. the risk of malformations such as neural tube\ny The review used for this PICO question only defects and cleft palate at birth (204). The\naddressed the global tolerability outcome, European Medical Agency (EMA) recommends\n“discontinuation due to adverse effects”. With avoiding sodium valproate in pregnancy and that",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety Strength of recommendation: Strong\nCertainty of evidence: Low\nJustification QT prolongation, sedation, which all appear in\ny Data were extracted from an NMA: Kishi et al., 2022 varying degrees.\n(included 72 RCTs on pharmacological treatment for y According to the systematic review used, the mood\nbipolar mania) (202). stabilizers which were effective – carbamazepine,\ny In the review, the antipsychotics aripiprazole, sodium valproate and lithium – have important\nasenapine, cariprazine, haloperidol, olanzapine, side-effects as well. Rare, but extremely serious\npaliperidone, quetiapine, risperidone side-effects are that carbamazepine is associated\nand ziprasidone and the mood stabilizers with the risk of Stevens-Johnson syndrome and toxic\ncarbamazepine, lithium and sodium valproate epidermal necrolysis (203).\noutperformed placebo significantly for the outcome y An important side-effect of sodium valproate is\nresponse to treatment. The effect sizes were small its teratogenic potential. It significantly increases\nto moderate. the risk of malformations such as neural tube\ny The review used for this PICO question only defects and cleft palate at birth (204). The\naddressed the global tolerability outcome, European Medical Agency (EMA) recommends\n“discontinuation due to adverse effects”. With avoiding sodium valproate in pregnancy and that Strength of recommendation: strong\ncertainty of evidence: low\njustification qt prolongation, sedation, which all appear in\ny data were extracted from an nma: kishi et al., 2022 varying degrees. (included 72 rcts on pharm..."
}